{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:20:05Z","timestamp":1787502005546,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Construction of clinical medical research center of Gansu Science and Technology project","award":["21JR7RA435"],"award-info":[{"award-number":["21JR7RA435"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360029"],"award-info":[{"award-number":["82360029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-67067-w","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T19:43:11Z","timestamp":1721418191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["DARS expression in BCR\/ABL1-negative myeloproliferative neoplasms and its association with the immune microenvironment"],"prefix":"10.1038","volume":"14","author":[{"given":"Hao","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liansheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"67067_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury, J. D. et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic\/dendritic neoplasms. Leukemia 36, 1703\u20131719 (2022).","journal-title":"Leukemia"},{"key":"67067_CR2","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1056\/NEJMra063728","volume":"355","author":"PJ Campbell","year":"2006","unstructured":"Campbell, P. J. & Green, A. R. The myeloproliferative disorders. N. Engl. J. Med. 355, 2452\u20132466 (2006).","journal-title":"N. Engl. J. Med."},{"key":"67067_CR3","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1056\/NEJMra1406186","volume":"376","author":"JL Spivak","year":"2017","unstructured":"Spivak, J. L. Myeloproliferative neoplasms. N. Engl. J. Med. 376, 2168\u20132181 (2017).","journal-title":"N. Engl. J. Med."},{"key":"67067_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10742-3","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. JAK2 inhibitors for the treatment of Philadelphia-negative myeloproliferative neoplasms: Current status and future directions. Mol. Divers. https:\/\/doi.org\/10.1007\/s11030-023-10742-3 (2023).","journal-title":"Mol. Divers."},{"key":"67067_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100714","volume":"42","author":"P Guglielmelli","year":"2020","unstructured":"Guglielmelli, P. & Vannucchi, A. M. Current management strategies for polycythemia vera and essential thrombocythemia. Blood Rev. 42, 100714 (2020).","journal-title":"Blood Rev."},{"key":"67067_CR6","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1111\/jth.15834","volume":"20","author":"N Gangat","year":"2022","unstructured":"Gangat, N. et al. Site-specific venous thrombosis in essential thrombocythemia: Impact on subsequent vascular events and survival. J. Thromb. Haemost. 20, 2439\u20132443 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"67067_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13045-020-00995-y","volume":"13","author":"S Venugopal","year":"2020","unstructured":"Venugopal, S. & Mascarenhas, J. Novel therapeutics in myeloproliferative neoplasms. J. Hematol. Oncol. 13, 162 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"67067_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11899-017-0403-0","volume":"12","author":"K Pettit","year":"2017","unstructured":"Pettit, K. & Odenike, O. Novel therapies for myelofibrosis. Curr. Hematol. Malig. Rep. 12, 611\u2013624 (2017).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"67067_CR9","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.3390\/cancers12071763","volume":"12","author":"MO Holmstrom","year":"2020","unstructured":"Holmstrom, M. O., Hasselbalch, H. C. & Andersen, M. H. Cancer immune therapy for Philadelphia chromosome-negative chronic myeloproliferative neoplasms. Cancers (Basel) 12, 1763 (2020).","journal-title":"Cancers (Basel)"},{"key":"67067_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"67067_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100425","volume":"2","author":"Z Shen","year":"2021","unstructured":"Shen, Z. et al. Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms. Cell Rep. Med. 2, 100425 (2021).","journal-title":"Cell Rep. Med."},{"key":"67067_CR12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/cancers13030482","volume":"13","author":"N Gomez-Cebrian","year":"2021","unstructured":"Gomez-Cebrian, N. et al. Polycythemia vera and essential thrombocythemia patients exhibit unique serum metabolic profiles compared to healthy individuals and secondary thrombocytosis patients. Cancers (Basel) 13, 482 (2021).","journal-title":"Cancers (Basel)"},{"key":"67067_CR13","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1182\/bloodadvances.2023010950","volume":"8","author":"M Usart","year":"2024","unstructured":"Usart, M. et al. The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN. Blood Adv. 8, 2312\u20132325 (2024).","journal-title":"Blood Adv."},{"key":"67067_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nri.2017.139","volume":"18","author":"EJ Pearce","year":"2018","unstructured":"Pearce, E. J. & Pearce, E. L. Immunometabolism in 2017: Driving immunity: All roads lead to metabolism. Nat. Rev. Immunol. 18, 81\u201382 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"67067_CR15","doi-asserted-by":"publisher","first-page":"7815","DOI":"10.1002\/cam4.5542","volume":"12","author":"A Bonometti","year":"2023","unstructured":"Bonometti, A. et al. Arginase-1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver. Cancer Med. 12, 7815\u20137822 (2023).","journal-title":"Cancer Med."},{"key":"67067_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.665037","volume":"11","author":"JG Cominal","year":"2021","unstructured":"Cominal, J. G. et al. Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms. Front. Oncol. 11, 665037 (2021).","journal-title":"Front. Oncol."},{"key":"67067_CR17","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1007\/s11064-022-03582-4","volume":"47","author":"M Klugmann","year":"2022","unstructured":"Klugmann, M. et al. Developmental delay and late onset HBSL pathology in hypomorphic Dars 1 (M256L) mice. Neurochem. Res. 47, 1972\u20131984 (2022).","journal-title":"Neurochem. Res."},{"key":"67067_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110323","volume":"128","author":"M Jiao","year":"2020","unstructured":"Jiao, M., Guo, H., Chen, Y., Li, L. & Zhang, L. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS. Biomed. Pharmacother. 128, 110323 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"67067_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf3984","volume":"9","author":"C Zheng","year":"2023","unstructured":"Zheng, C. et al. Multiomics analyses reveal DARS1-AS1\/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis\/radioresistance. Sci. Adv. 9, eadf3984 (2023).","journal-title":"Sci. Adv."},{"key":"67067_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/path.5980","volume":"258","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. Functional genomics screening identifies aspartyl-tRNA synthetase as a novel prognostic marker and a therapeutic target for gastric cancers. J. Pathol. 258, 106\u2013120 (2022).","journal-title":"J. Pathol."},{"key":"67067_CR21","first-page":"3342","volume":"13","author":"G Tu","year":"2023","unstructured":"Tu, G. et al. hsa_circ_0000519 promotes the progression of lung adenocarcinoma through the hsa-miR-1296-5p\/DARS axis. Am. J. Cancer Res. 13, 3342\u20133367 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"67067_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035452","volume":"102","author":"L Tan","year":"2023","unstructured":"Tan, L. et al. NIFK as a potential prognostic biomarker in colorectal cancer correlating with immune infiltrates. Medicine (Baltimore) 102, e35452 (2023).","journal-title":"Medicine (Baltimore)"},{"key":"67067_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","volume":"8","author":"T Barbui","year":"2018","unstructured":"Barbui, T. et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: Document summary and in-depth discussion. Blood Cancer J. 8, 15 (2018).","journal-title":"Blood Cancer J."},{"key":"67067_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bcmd.2018.12.004","volume":"75","author":"L Cottin","year":"2019","unstructured":"Cottin, L. et al. WT1 gene is overexpressed in myeloproliferative neoplasms, especially in myelofibrosis. Blood Cells Mol. Dis. 75, 35\u201340 (2019).","journal-title":"Blood Cells Mol. Dis."},{"key":"67067_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86099-0","volume":"11","author":"K Mitachi","year":"2021","unstructured":"Mitachi, K. et al. Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer. Sci. Rep. 11, 6541 (2021).","journal-title":"Sci. Rep."},{"key":"67067_CR26","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s12032-011-0144-1","volume":"29","author":"CC Ponce","year":"2012","unstructured":"Ponce, C. C., de Lourdes, F. C. M., Ihara, S. S. & Silva, M. R. The relationship of the active and latent forms of TGF-beta1 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis. Med. Oncol. 29, 2337\u20132344 (2012).","journal-title":"Med. Oncol."},{"key":"67067_CR27","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","volume":"124","author":"A Tefferi","year":"2014","unstructured":"Tefferi, A. et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood 124, 2507\u20132513 (2014) (quiz 2615).","journal-title":"Blood"},{"key":"67067_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11899-020-00588-z","volume":"15","author":"C Galvez","year":"2020","unstructured":"Galvez, C. & Stein, B. L. Thrombocytosis and thrombosis: Is there really a correlation?. Curr. Hematol. Malig. Rep. 15, 261\u2013267 (2020).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"67067_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3343\/alm.2018.38.4.296","volume":"38","author":"N Yang","year":"2018","unstructured":"Yang, N. et al. GATA1 expression in BCR\/ABL1-negative myeloproliferative neoplasms. Ann. Lab. Med. 38, 296\u2013305 (2018).","journal-title":"Ann. Lab. Med."},{"key":"67067_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2016.08.016","volume":"25","author":"K Man","year":"2017","unstructured":"Man, K., Kutyavin, V. I. & Chawla, A. Tissue immunometabolism: Development, physiology, and pathobiology. Cell Metab. 25, 11\u201326 (2017).","journal-title":"Cell Metab."},{"key":"67067_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2020.06.010","volume":"32","author":"B Kelly","year":"2020","unstructured":"Kelly, B. & Pearce, E. L. Amino assets: How amino acids support immunity. Cell Metab. 32, 154\u2013175 (2020).","journal-title":"Cell Metab."},{"key":"67067_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.626610","volume":"14","author":"A Muthiah","year":"2020","unstructured":"Muthiah, A., Housley, G. D., Klugmann, M. & Frohlich, D. The leukodystrophies HBSL and LBSL-correlates and distinctions. Front. Cell Neurosci. 14, 626610 (2020).","journal-title":"Front. Cell Neurosci."},{"issue":"1013\u20131026","key":"67067_CR33","volume":"33","author":"AS Krall","year":"2021","unstructured":"Krall, A. S. et al. Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth. Cell Metab. 33(1013\u20131026), e1016 (2021).","journal-title":"Cell Metab."},{"key":"67067_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 169, 361\u2013371 (2017).","journal-title":"Cell"},{"key":"67067_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ncrna.2023.09.005","volume":"8","author":"X Jiang","year":"2023","unstructured":"Jiang, X. et al. miR-624 accelerates the growth of liver cancer cells by inhibiting EMC3. Noncoding RNA Res. 8, 641\u2013644 (2023).","journal-title":"Noncoding RNA Res."},{"key":"67067_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11899-014-0227-0","volume":"9","author":"G Barosi","year":"2014","unstructured":"Barosi, G. An immune dysregulation in MPN. Curr. Hematol. Malig. Rep. 9, 331\u2013339 (2014).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"67067_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003059","author":"S Huang","year":"2024","unstructured":"Huang, S. et al. Association of the expression of Th1\/Th2 cytokines and lymphocyte subsets with clinical characteristics and outcomes in 207 Chinese children with Burkitt\u2019s lymphoma. Chin. Med. J. (Engl.) https:\/\/doi.org\/10.1097\/CM9.0000000000003059 (2024).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"67067_CR38","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","volume":"298","author":"ME Dudley","year":"2002","unstructured":"Dudley, M. E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850\u2013854 (2002).","journal-title":"Science"},{"key":"67067_CR39","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1200\/JCO.2003.12.144","volume":"21","author":"AC Peterson","year":"2003","unstructured":"Peterson, A. C., Harlin, H. & Gajewski, T. F. Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma. J. Clin. Oncol. 21, 2342\u20132348 (2003).","journal-title":"J. Clin. Oncol."},{"key":"67067_CR40","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.2147\/JIR.S366761","volume":"15","author":"H Bian","year":"2022","unstructured":"Bian, H. et al. Expression and clinical significance of Th1\/Th2\/Th17 cytokines and lymphocyte subsets in PCNSL. J. Inflamm. Res. 15, 3815\u20133828 (2022).","journal-title":"J. Inflamm. Res."},{"key":"67067_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ctrv.2018.08.010","volume":"70","author":"SQ Qiu","year":"2018","unstructured":"Qiu, S. Q. et al. Tumor-associated macrophages in breast cancer: Innocent bystander or important player?. Cancer Treat. Rev. 70, 178\u2013189 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"67067_CR42","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/his.15125","volume":"84","author":"JJX Li","year":"2024","unstructured":"Li, J. J. X. et al. Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and tumour-associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy. Histopathology 84, 810\u2013821 (2024).","journal-title":"Histopathology"},{"key":"67067_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/1479-5876-9-216","volume":"9","author":"M Heusinkveld","year":"2011","unstructured":"Heusinkveld, M. & van der Burg, S. H. Identification and manipulation of tumor associated macrophages in human cancers. J. Transl. Med. 9, 216 (2011).","journal-title":"J. Transl. Med."},{"key":"67067_CR44","first-page":"77","volume":"30","author":"ZH Liu","year":"2022","unstructured":"Liu, Z. H., Wang, P. P. & Yan, X. J. The expression and clinical correlation of the CD68 factor in acute myeloid leukemia patients. Zhongguo Shi Yan Xue Ye Xue Za Zhi 30, 77\u201383 (2022).","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"67067_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32645-x","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade. Nat. Commun. 13, 4948 (2022).","journal-title":"Nat. Commun."},{"key":"67067_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.877278","volume":"13","author":"S Xin","year":"2022","unstructured":"Xin, S. et al. The prognostic signature and therapeutic value of phagocytic regulatory factors in prostate adenocarcinoma (PRAD). Front. Genet. 13, 877278 (2022).","journal-title":"Front. Genet."},{"key":"67067_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156289","volume":"169","author":"C Bao","year":"2023","unstructured":"Bao, C. et al. Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes. Cytokine 169, 156289 (2023).","journal-title":"Cytokine"},{"key":"67067_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature. 454, 436\u2013444 (2008).","journal-title":"Nature."},{"key":"67067_CR49","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","volume":"28","author":"D Hormaechea-Agulla","year":"2021","unstructured":"Hormaechea-Agulla, D. et al. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNgamma signaling. Cell Stem Cell 28, 1428-1442 e1426 (2021).","journal-title":"Cell Stem Cell"},{"key":"67067_CR50","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4049\/jimmunol.178.1.280","volume":"178","author":"MA Burchill","year":"2007","unstructured":"Burchill, M. A., Yang, J., Vogtenhuber, C., Blazar, B. R. & Farrar, M. A. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280\u2013290 (2007).","journal-title":"J. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67067-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67067-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67067-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T19:54:21Z","timestamp":1721418861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67067-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["67067"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-67067-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16711"}}